The gut microbiome and nonalcoholic fatty liver disease: prospects for drug therapy
Open Access
- 10 December 2024
- journal article
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 10,p. 178-187
Abstract
Nonalcoholic fatty liver disease (NAFLD) is most commonly a component of the metabolic syndrome with a global prevalence of 25% and the number of patients continues to increase. According to current projections, in the near future, NAFLD will become the most common indication for liver transplantation. The search for new risk factors for the development and progression of this disease is actively underway. The article considers the role of intestinal microbiota in proinflammatory processes, bile acid metabolism and liver lipogenesis. Attention is paid to the qualitative composition of the microbiome depending on the stage of NAFLD. Conclusions are made about heterogeneity of the research results in case of NAFLD and relatively stable microbiota in liver cirrhosis. Faecalibacterium prausnitzii and its role in the progression of NAFLD are considered separately. Probable reasons for the disagreement of the results of the studies are presented. In the part devoted to the treatment of NAFLD, the focus is on the ways of correction of intestinal dysbiosis, the influence of various microbiological preparations on lipogenesis and the process of inflammation in the liver. The optimal composition of probiotic preparations is discussed in detail. Their combination with prebiotics and isolated administration of inulin, fructooligosaccharide. Conclusions are drawn that in the future the assessment of intestinal microbiome will help to improve therapeutic approaches in the treatment of NAFLD patients.Keywords
This publication has 102 references indexed in Scilit:
- Soluble Fibers Improve Metabolic Syndrome but May Cause Liver Disease and Hepatocellular CarcinomaHepatology, 2019
- A synbiotic composed of Lactobacillus fermentum CECT5716 and FOS prevents the development of fatty acid liver and glycemic alterations in rats fed a high fructose diet associated with changes in the microbiotaMolecular Nutrition & Food Research, 2017
- Bile acids and nonalcoholic fatty liver diseaseHepatology, 2017
- Interaction between gut microbiota and toll-like receptor: from immunity to metabolismJournal of Molecular Medicine, 2016
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiotaHepatology, 2015
- Role of farnesoid X receptor in inflammation and resolutionInflammation Research, 2014
- Characterization of Gut Microbiomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection Between Endogenous Alcohol and NASHHepatology, 2012
- Characterization of fecal microbial communities in patients with liver cirrhosisHepatology, 2011
- Increased Fructose Consumption Is Associated With Fibrosis Severity in Patients With Nonalcoholic Fatty Liver DiseaseHepatology, 2010